Company: SRPT
Filing Date: 2025-04-24
Form Type: DEF 14A
Source: 0000950170-25-058003
Chunk: 88

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-04-24
Form: DEF 14A
Chunk 88
---
167,186 |
|     |      |               |        11,821 |     |   |        15,179 |     | -4 |     |                                                                                            | $ |   155.99 |     | 3/6/2033 |            |              |        3,375 |     | -10 | $ |      410,366 |     | — |              |     |     | — |               |
|     |      | —             |               |     | — |               |     |    |     |                                                                                            | — |          |     | 3/6/2033 |            |              |       17,500 |     | -11 | $ |    2,127,825 |     | — |              |     |     | — |               |
|     |      | —             |               |     |   |        12,500 |     | -5 |     |                                                                                            | $ |   128.67 |     | 3/1/2034 |            |              |        6,000 |     | -12 | $ |      729,540 |     | — |              |     |     | — |               |
|     |      | —             |               |     | — |               |     |    |     |                                                                                            | — |          |     | 3/1/2034 |            | —            |              |     |     | — |              |     |   |        7,500 |     | -16 | $ |       911,925 |

(1) This stock option vests between the effective date of its modification on April 19, 2022 and June 26, 2025, subject to service and market conditions as described below under “ Compensation Agreements for Named Executive Officers Douglas S. Ingram – President and Chief Executive Officer ”. (2) This stock option fully vested on March 3, 2025, and vested at a rate of 25% of the shares of our common stock underlying the option on March 3, 2022 and 1/48th of the shares of our common stock underlying the option on each monthly anniversary thereafter, subject to each such holder continuing to provide services to the Company through each such vesting date. (3) This stock option fully vests on March 7, 2026, and vests at a rate of 25% of the shares of our common stock underlying the option on March